Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
Clinical trial NCT06475820 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06475820
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-07-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.